advertisement

Topcon

Harada C 14

Showing records 1 to 14 | Display all abstracts from Harada C

70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Guo X
Scientific reports 2016; 6: 33950
70256 Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration
Kimura A
International journal of molecular sciences 2016; 17:
70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Kimura A; Namekata K
Histology and Histopathology 2017; 32: 215-221
70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Kimura A
Scientific reports 2016; 6: 33950
70256 Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration
Namekata K
International journal of molecular sciences 2016; 17:
70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Guo X
Histology and Histopathology 2017; 32: 215-221
70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Azuchi Y
Scientific reports 2016; 6: 33950
70256 Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration
Guo X
International journal of molecular sciences 2016; 17:
70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Akiyama G
Scientific reports 2016; 6: 33950
70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Harada C
Histology and Histopathology 2017; 32: 215-221
70256 Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration
Harada C
International journal of molecular sciences 2016; 17:
70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Harada T
Histology and Histopathology 2017; 32: 215-221
70256 Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration
Harada T
International journal of molecular sciences 2016; 17:
70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Noro T; Harada C; Namekata K; Harada T
Scientific reports 2016; 6: 33950

Issue 18-2

Change Issue


advertisement

Oculus